UPMC Hillman Cancer Center - Passavant - Cranberry is a clinical research site located in Cranberry Township, Pennsylvania, United States 16066.
Crixeo Health Trust Score: 78/100 (FAIR). This profile has not yet been claimed by the site owner.
UPMC Hillman Cancer Center - Passavant - Cranberry has participated in 22 clinical trials with 20 currently active.
Therapeutic areas: Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8.
Sponsors: SWOG Cancer Research Network, National Cancer Institute (NCI), ECOG-ACRIN Cancer Research Group.
Trust Score: 78/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
UPMC Hillman Cancer Center - Passavant - Cranberry has a Crixeo Trust Score of 78/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
UPMC Hillman Cancer Center - Passavant - Cranberry has 22 clinical trials on record, with 20 currently active. Their work covers Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8.
Yes — UPMC Hillman Cancer Center - Passavant - Cranberry holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.